Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-09

FDA Approved: CHOLESTYRAMINE — Original Application (Precision Dose, Inc.)

View source ↗

Summary

FDA approved an original ANDA for cholestyramine from Precision Dose, Inc., providing a generic version of the bile acid sequestrant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholestyramine (cholestyramine)

Snippet

ORIG AP for CHOLESTYRAMINE (CHOLESTYRAMINE)